MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 12, 2020

Total Value ($000): $376,116 (100.0% shares, 0.0% debt)

Holdings (11)

— Repare Therapeutics, Inc. 19.7%

Value ($000) $74,086 Shares 2,388,337 Est. Cost $31.02 Unrealized —

— Harpoon Therapeutics, Inc. 17.2%

Value ($000) $64,714 Shares 3,898,422 Est. Cost $14.79 Unrealized —

— TCR2 Therapeutics, Inc. 13.8%

Value ($000) $51,778 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— MEI Pharma, Inc. 11.1%

Value ($000) $41,869 Shares 10,137,859 Est. Cost $3.11 Unrealized —

— Epizyme, Inc. 10.0%

Value ($000) $37,444 Shares 2,331,534 Est. Cost $24.60 Unrealized —

— G1 Therapeutics, Inc. 9.2%

Value ($000) $34,541 Shares 1,423,794 Est. Cost $26.43 Unrealized —

ADCT ADC Therapeutics, Inc. 6.7%

Value ($000) $25,261 Shares 539,648 Est. Cost $38.22 Unrealized 0.0%

— Turning Point Therapeutics, Inc. 5.3%

Value ($000) $19,938 Shares 308,686 Est. Cost $44.66 Unrealized —

— YmAbs Therapeutics, Inc. 3.9%

Value ($000) $14,571 Shares 337,291 Est. Cost $31.25 Unrealized —

— Merus N.V. 3.0%

Value ($000) $11,277 Shares 700,879 Est. Cost $16.09 Unrealized —

AUTL Autolus Therapeutics Limited 0.2%

Value ($000) $637 Shares 39,740 Est. Cost $13.21 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Repare Therapeutics, Inc.	2,388,337	$74,086	19.7%	$31.02	—	Common	760273102
—	Harpoon Therapeutics, Inc.	3,898,422	$64,714	17.2%	$14.79	—	Common	41358P106
—	TCR2 Therapeutics, Inc.	3,370,982	$51,778	13.8%	$14.28	—	Common	87808K106
—	MEI Pharma, Inc.	10,137,859	$41,869	11.1%	$3.11	—	Common	552798202
—	Epizyme, Inc.	2,331,534	$37,444	10.0%	$24.60	—	Common	29428V104
—	G1 Therapeutics, Inc.	1,423,794	$34,541	9.2%	$26.43	—	Common	3621LQ109
ADCT	ADC Therapeutics, Inc.	539,648	$25,261	6.7%	$38.22	0.0%	Common	H0036K147
—	Turning Point Therapeutics, Inc.	308,686	$19,938	5.3%	$44.66	—	Common	90041T108
—	YmAbs Therapeutics, Inc.	337,291	$14,571	3.9%	$31.25	—	Common	984241109
—	Merus N.V.	700,879	$11,277	3.0%	$16.09	—	Common	N5749R100
AUTL	Autolus Therapeutics Limited	39,740	$637	0.2%	$13.21	—	Common	05280R100